Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dement Geriatr Cogn Disord ; 53(2): 47-56, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38479371

RESUMO

INTRODUCTION: Cognitive screening measures are an established part of a dementia assessment and often include measures of subjective difficulties, e.g., Everyday Memory Questionnaire (EMQ), informant-rated difficulty, Cambridge Behavioural Inventory - Revised (CBI-R), and objective cognitive assessments like Addenbrooke's Cognitive Examination (ACE-III). While these measures have validity for the purpose of diagnosing dementia, in clinical practice they are often used outside of their evidence base for the purpose of cognitive re-assessment. The current study sought to evaluate the psychometric properties for the repeated use of these assessments. METHODS: This study used a longitudinal design, which included 49 healthy controls, 33 people with subjective memory difficulties, and 10 people with Alzheimer's disease (AD) being assessed twice, with approximately a 1-year interval between assessments. RESULTS: The EMQ has adequate re-test reliability (r = 0.78), but people with an AD diagnosis rated their memory as better than those with SMD, making it unsuitable as a measure. The CBI-R had moderate re-test reliability (r = 0.62). However, deterioration on the CBI-R was not useful for diagnosing AD. The ACE-III has high re-test reliability (r = 0.89). A change of five was associated with reasonable classification accuracy for identifying AD and achieved statistical significance. CONCLUSION: Using a 1-year interval, of the three measures used in this study, only the ACE-III total score may be a useful measure of change over time, although it should be applied cautiously due to the lack of representativeness of the sample, and change scores should always be triangulated with other forms of evidence of deterioration.


Assuntos
Doença de Alzheimer , Demência , Testes Neuropsicológicos , Psicometria , Humanos , Masculino , Feminino , Idoso , Reprodutibilidade dos Testes , Demência/diagnóstico , Estudos Longitudinais , Doença de Alzheimer/diagnóstico , Doença de Alzheimer/psicologia , Idoso de 80 Anos ou mais , Inquéritos e Questionários , Pessoa de Meia-Idade , Transtornos da Memória/diagnóstico , Testes de Estado Mental e Demência
2.
J Clin Exp Neuropsychol ; 45(5): 445-451, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37621191

RESUMO

INTRODUCTION: Cognitive assessments, such as the Addenbrooke's Cognitive Examination (ACE-III) and Montreal Cognitive Assessment (MoCA), have been modified for administration using tablet computers. While this offers important advantages for practice, it may also threaten the test validity. The current study sought to test whether administering visuospatial and writing tests using a tablet (finger or stylus drawing), would demonstrate equivalence to traditional pencil and paper administration on ACEmobile. METHOD: This study recruited 26 participants with Alzheimer's disease and 23 healthy older adults. Most participants had low familiarity with using a tablet computer. Participants completed ACEmobile in its entirety, after which they repeated the infinity loops, cube, and clock drawing and sentence writing tests by drawing with a stylus and their finger onto an iPad. Performance on the drawing and writing tests using a stylus, finger, and pencil were compared. RESULTS: Statistically significant differences were observed between the finger and pencil administration on the ACEmobile, with participants performing worse on the finger drawing trials. Differences in scores were most apparent on the sentence writing task. In contrast, no statistical differences were observed between the pencil and stylus administration. DISCUSSION: The findings of this pilot study have important implications for clinical neuropsychology and demonstrate that administering ACEmobile drawing tests with finger drawing is invalid. However, due to the small sample size, a lack of counterbalancing and the narrow range of scores of the dependent variable, we are unable to confidently interpret the validity of stylus drawing. This is an important consideration for future research.


Assuntos
Doença de Alzheimer , Disfunção Cognitiva , Humanos , Idoso , Projetos Piloto , Dedos , Testes de Estado Mental e Demência , Exame Neurológico , Testes Neuropsicológicos , Disfunção Cognitiva/psicologia
3.
Dement Geriatr Cogn Disord ; 52(4): 195-204, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37271132

RESUMO

INTRODUCTION: Visual and spatial perception (VSP) are cognitive domains frequently assessed in the screening and neuropsychological assessment of dementia. Evidence suggests that VSP impairment is common in the early stages of Alzheimer's disease (AD). Despite this evidence, the ability of VSP tests to discriminate between healthy older adults and people with AD remains mixed. The purpose of this literature review was to employ a systematic search strategy to identify empirical evidence supporting the diagnostic utility of VSP tests which may be used in the screening and diagnosis of AD. METHODS: Specified criteria were used to perform a systematic literature search of the PsycINFO and PubMed databases with no date restrictions. Relevant data from the selected studies were extracted, and a published appraisal tool (the Quality Assessment of Diagnostic Accuracy Studies-2) was used to evaluate methodological quality. RESULTS: Of the 144 articles returned, six studies and 11 VSP tests met review inclusion criteria. Four tests demonstrated both sensitivity and specificity values above 80%. A computerised 3D Visual Task demonstrated the highest sensitivity and specificity values (90% and 95%, respectively). The quality of the identified studies was considered to be satisfactory. Identified limitations and the implications of issues relating to study methodology are discussed, and recommendations for future research are suggested. CONCLUSION: The evidence from this review suggests that certain tests of VSP may be a useful addition to the routine screening of AD.


Assuntos
Doença de Alzheimer , Disfunção Cognitiva , Demência , Humanos , Idoso , Doença de Alzheimer/diagnóstico , Demência/diagnóstico , Disfunção Cognitiva/diagnóstico , Testes Neuropsicológicos , Percepção , Sensibilidade e Especificidade
4.
J Neuropsychol ; 17(3): 491-504, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37186035

RESUMO

The Oxford cognitive screen (OCS) is a stroke-specific cognitive screening assessment. Although the test developers have provided psychometric information for the assessment, the OCS has received minimal external scrutiny, with which to triangulate the underpinning psychometrics. The purpose of this study is to provide a critical review and independent validation of the OCS. This study analysed data from an anonymised clinical database, which consisted of 316 patients who were assessed using the OCS on an Acute Stroke Unit. The rates of impairment on tests of memory and receptive communication were lower than expectation, suggesting that these subtests may be relatively insensitive. Patients with aphasia were more likely to be unable to categorised as impaired on non-language tests, suggesting that they remain sensitive to language processing or non-dominant hand usage. Some of the subtests of the OCS achieve high retest reliability, which makes them good candidates for measuring cognitive change over time. Although the OCS has many advantages, it is also important to adequately consider its limitations, that is insensitivity to memory problems, the potential confounding impact of non-dominant hand usage, and the potential that some tests may sample overall cognitive ability instead of domain-specific functioning.


Assuntos
Afasia , Transtornos Cognitivos , Disfunção Cognitiva , Acidente Vascular Cerebral , Humanos , Psicometria , Reprodutibilidade dos Testes , Afasia/psicologia , Transtornos Cognitivos/diagnóstico , Acidente Vascular Cerebral/psicologia , Cognição , Testes Neuropsicológicos , Disfunção Cognitiva/diagnóstico
5.
Neuropsychol Rehabil ; 33(3): 480-496, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35152850

RESUMO

Post stroke anxiety is associated with reduced quality of life, worse rehabilitation outcomes and poor social functioning in stroke survivors. Despite its clinical relevance, there are a lack of screening tools to identify post-stroke anxiety. The Hospital Anxiety and Depression Scale (HADS-A) and Geriatric Anxiety Inventory (GAI) are the only self-report screening test for anxiety validated in stroke patients. However, both of these measures have limitations associated with their clinical utility, length of time to administer and cost to purchase. This study aimed to assess the classiciation accuracy of a freely available and shorter alternative, the Generalized Anxiety Disorder 2-item (GAD-2) for use in the acute stroke setting. This study used retrospective analysis of a sequential sample in a clinical database of mood and cognitive scores. Patients' scores on the GAD-2 and HADS-A were compared. The GAD-2 demonstrated strong convergent validity with the HADS-A and good specificity and sensitivity for clinical anxiety. In conclusion, the GAD-2 may be a useful screening assessment of post-stroke anxiety in the acute setting; however, it should be used with due consideration of the methodological limitations of this study.


Assuntos
Questionário de Saúde do Paciente , Acidente Vascular Cerebral , Humanos , Idoso , Qualidade de Vida , Estudos Retrospectivos , Sensibilidade e Especificidade , Psicometria , Escalas de Graduação Psiquiátrica , Reprodutibilidade dos Testes , Ansiedade/diagnóstico , Ansiedade/etiologia , Transtornos de Ansiedade/diagnóstico , Transtornos de Ansiedade/etiologia , Acidente Vascular Cerebral/complicações , Acidente Vascular Cerebral/psicologia , Depressão/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...